0000897101-15-001472.txt : 20151103 0000897101-15-001472.hdr.sgml : 20151103 20151103170956 ACCESSION NUMBER: 0000897101-15-001472 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151103 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151103 DATE AS OF CHANGE: 20151103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTRICON CORP CENTRAL INDEX KEY: 0000088790 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS & ACCESSORIES [3670] IRS NUMBER: 231069060 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05005 FILM NUMBER: 151194534 BUSINESS ADDRESS: STREET 1: 1260 RED FOX ROAD CITY: ARDEN HILLS STATE: MN ZIP: 55112 BUSINESS PHONE: 6516369770 MAIL ADDRESS: STREET 1: 1260 RED FOX ROAD CITY: ARDEN HILLS STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: SELAS CORP OF AMERICA DATE OF NAME CHANGE: 19920703 8-K 1 intricon153792_8k.htm FORM 8-K DATED NOVEMBER 3, 2015

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  November 3, 2015

 

 

INTRICON CORPORATION

(Exact name of registrant as specified in its charter)

 

Pennsylvania 1-5005 23-1069060
(State or other jurisdiction of
incorporation)
(Commission File Number) (IRS Employer Identification No.)

 

 

1260 Red Fox Road, Arden Hills, MN 55112

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code  (651) 636-9770

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 

 

Item 7.01   Regulation FD Disclosure.

 

On November 3, 2015, IntriCon Corporation (the “Company”) issued a press release concerning the acquisition of the assets of PC Werth Ltd. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01   Financial Statements and Exhibits.
     
(d)   Exhibits.
     
Exhibit No.   Description
99.1   Press Release dated November 3, 2015.

 

 

 

 

 

 

 

 

 

 

 

 

1 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INTRICON CORPORATION
     
  By:   /s/ Scott Longval
  Name:   Scott Longval
  Title:   Chief Financial Officer

 

Date:  November 3, 2015

 

 

 

 

 

 

 

S-1 
 

Exhibit Index

 

 

Exhibit No.

Description

99.1 Press Release dated November 3, 2015.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E-1 
EX-99.1 2 intricon153792_ex99-1.htm PRESS RELEASE DATED NOVEMBER 3, 2015

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

 

INTRICON ACQUIRES PC WERTH LTD
Company Gains Direct Access to U.K.’s National Health Service, Greater Control Over Sales
and Marketing Initiatives

 

ARDEN HILLS, Minn. — November 3, 2015 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced that it has acquired, effective today, assets of PC Werth Ltd, a leading supplier of hearing healthcare products and equipment to the United Kingdom’s National Health Service (NHS).

In December 2014, IntriCon entered into an exclusive agreement with PC Werth Ltd, to distribute its high-quality hearing aid products in the United Kingdom. By acquiring PC Werth, IntriCon gains direct access to the NHS and greater control over its efforts to accelerate new market penetration in the United Kingdom.

As previously noted, the NHS is the largest purchaser of hearing aids in the world, supplying an estimated 1.4 million hearing aids annually. Post integration, IntriCon expects the acquisition will generate $4.5 million to $5.5 million in revenue on an annualized basis, and be accretive to earnings per share.

The transaction will require various NHS contracts to be novated, which the company anticipates completing in 2015. Going forward, IntriCon will continue to use the PC Werth tradename and Kamplex brand. Key management of PC Werth will be retained as part of the transaction.

Said Mark Gorder, president and chief executive officer of IntriCon, “Our acquisition of PC Werth provides IntriCon a solid foundation to expand our presence in the U.K. and establishes a direct link to the NHS. An immediate initiative will be to increase our sales and market efforts to drive NHS market share. The NHS is widely recognized as the most efficient hearing aid delivery system in the world, and we believe we are well-positioned to serve their needs.”

 

(more)

 

 
 

 

IntriCon Corporation

Nov. 3, 2015

Page 2

 

 

About PC Werth Ltd

Established in 1947 by Peter Werth, PC Werth played an instrumental role establishing the U.K.’s independent hearing healthcare sector and was instrumental in developing the U.K. business for three of the world’s six largest hearing aid manufacturers. Now a leading supplier of hearing healthcare products and equipment to the NHS and all hearing healthcare practitioners, PC Werth also supplies communication products and associated services to schools and learning establishments. For more information about PC Werth, visit http://www.pcwerth.co.uk.

 

About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops, manufactures and distributes miniature and micro-miniature body-worn devices. The company is focused on three key markets: medical, hearing health, and professional audio communications. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.

 

Forward-Looking Statements

Statements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and other factors are detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2014. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.

 

Contacts

At IntriCon:
Scott Longval, CFO
651-604-9526
slongval@intricon.com
At PadillaCRT:
Matt Sullivan
612-455-1700
matt.sullivan@padillacrt.com

 

 

 

###